Predictive Assays for the Therapy of Rectal Carcinoma
The decision about the therapeutic treatment of an individual tumor is made on the basis of the localization and the clinical as well as the histopathological staging. However, very different responses to such a treatment are observed for tumors with the same clinical and histopathological stage. From this general clinical expe rience it can be concluded that these tumors differ very much in their individual biological characteristics, which are relevant for the therapeutic response, and more biological data are needed in order to improve the selection of the appropriate therapeutic modality on an individual basis as well as to obtain better prognostic factors [1, 2].
KeywordsBromide Fractionation Oncol Ethidium
Unable to display preview. Download preview PDF.
- 1.Mitchell JS, Feinendegen LE (1984) Research on the biological individualisation of cancer radiotherapy including the problems of developing countries. Report of meeting of experts, 26–30 April 1982. Strahlentherapie 160: 641–653Google Scholar
- 3.Alper T (1979) Cellular radiobiology. Cambridge University Press, CambridgeGoogle Scholar
- 4.Streffer C (1980) Biologische Grundlagen der Strahlentherapie. In: Scherer E (ed) Strahlentherapie. Springer, Berlin Heidelberg New York, pp 197–266Google Scholar
- 14.Wending P, Manz R, Thews G, Vaupel P (1984) Heterogeneous oxygenation of rectal carcinomas in humans. A critical parameter for preoperative irradiation? Adv Exp Med Biol 180: 293–300Google Scholar